Skip to main content
SpringerLink
Log in

Prevention of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Mother-to-Child Transmission

  • Chapter
  • First Online:
Adult T-cell Leukemia/Lymphoma

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic human retrovirus of adult T-cell leukemia/lymphoma (ATL). The estimated risk for an HTLV-1 carrier to develop ATL is approximately 5%. However, to date, medical treatments for ATL are not effective, and therefore the prognosis for this disease is poor. The vertical transmission of HTLV-1 occurs predominantly through breastfeeding. Therefore, for the prevention of mother-to-child transmission, bottle-feeding is the most effective method to prevent the endemic cycle of HTLV-1. When vertical transmission of HTLV-1 is prevented, the incidence of ATL is significantly reduced in the next generation. In Nagasaki prefecture, which is one of the endemic areas for HTLV-1 in Japan, prefecture-wide screening of pregnant women and advice to refrain from breastfeeding by carrier mothers have been implemented since 1987. HTLV-1-positive women are provided with counseling about methods of feeding, i.e., bottle-feeding, short-term breastfeeding, and freeze-thawing of breast milk, to reduce the risk of HTLV-1 mother-to-child transmission. A recent study of HTLV-1 carriers in Japan showed that the estimated number of HTLV-1 carriers in 2007 was one million and that HTLV-1 carriers have spread to other geographical areas in Japan (prevalence has decreased in endemic areas but increased in metropolitan areas). Therefore, in Japan, since 2011, the nationwide screening of pregnant women for HTLV-1 infection has been recommended to prevent breast milk-borne transmission of HTLV-1. In this chapter, critical points regarding the prevention program for mother-to-child transmission of HTLV-1 are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. De Thé G, Kazanji M. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(Suppl 1):S191–8.

    Article  PubMed  Google Scholar 

  2. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;15(3):388.

    Google Scholar 

  3. Tajima K. The 4th nationwide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer. 1990;45:237–43.

    Article  CAS  PubMed  Google Scholar 

  4. Katsuya H, Yamanaka T, Ishitsuka K, et al. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma. J Clin Oncol. 2012;30(14):1635–40.

    Article  CAS  PubMed  Google Scholar 

  5. Tsukasaki K, Tobinai K. Biology and treatment of HTLV-1 associated T-cell lymphomas. Best Pract Res Clin Haematol. 2013;26:3–14.

    Article  CAS  PubMed  Google Scholar 

  6. Yamaguchi K, Watanabe T, Uchimaru K et al. A guidance for HTLV-1 carriers. Ministry of Health, Labour and Welfare, Tokyo. Available via: http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou19/dl/htlv-1_d.pdf. Accessed 22 Apr 2016 (in Japanese).

  7. Moriuchi H, Masuzaki H, Doi H, et al. Mother-to-child transmission of human T-cell lymphotropic virus type 1. Pediatr Infect Dis J. 2013;32(2):175–7.

    Article  PubMed  Google Scholar 

  8. De Thé G, Bomford R. An HTLV-1 vaccine: why, how, for whom? AIDS Res Hum Retrovir. 1993;9:381–6.

    Article  PubMed  Google Scholar 

  9. Hino S, Katamine MH, et al. Primary prevention of HTLV-1 in Japan. Leukemia. 1997;11(Suppl 3):57–9.

    PubMed  Google Scholar 

  10. Minakami H, Maeda T, Fujii T. Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition. J Obstet Gynaecol Res. 2014;40:1469–99.

    Article  PubMed  Google Scholar 

  11. Hino S. Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:152–66.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Oki T, Yoshinaga M, Otsuka H. Asero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu, Japan. Asia Ocean J Obstet Gynaecol. 1992;18(4):371–7.

    Article  CAS  Google Scholar 

  13. Wiktor SZ, Pate EJ, Rosenberg PS, et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol. 1997;1(1):37–44.

    CAS  PubMed  Google Scholar 

  14. Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84:327–35.

    Article  PubMed  Google Scholar 

  15. Watanabe T. Current status of HTLV-1 infection. Int J Hematol. 2011;94:430–4.

    Article  PubMed  Google Scholar 

  16. Nerome Y, Kojyo K, Ninomiya Y, et al. Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in Kagoshima. Pediatr Int. 2014;56(4):640–3.

    Article  PubMed  Google Scholar 

  17. The Committee of ATL Prevention Program Nagasaki (APP Nagasaki), Child Welfare Bureau of Nagasaki Prefecture. Report of joint study on the prevention of ATL by blocking mother-to-child transmission of HTLV-1: experiences and perspectives of 20 years. Nagasaki: Nagasaki Prefecture; 2008. p. 1–21. (in Japanese)

    Google Scholar 

  18. Hanaoka M, Kubo T, Saitoh A. Discrepancy between human T-cell lymphotropic virus type I screening test and confirmatory tests in non-endemic areas. J Obstet Gynaecol Res. 2012;38:793–6.

    Article  PubMed  Google Scholar 

  19. Katamine S, Moriuchi R, Yamamoto T, et al. HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers. Lancet. 1994;343(8909):1326–7.

    Article  CAS  PubMed  Google Scholar 

  20. Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, et al. Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer. 1999;82(6):832–6.

    Article  CAS  PubMed  Google Scholar 

  21. Li HC, Biggar RJ, Miley WJ, et al. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis. 2004;190(7):1275–8.

    Article  PubMed  Google Scholar 

  22. Carneiro-Proietti AB, Amaranto-Damasio MS, Leal-Horiguchi CF, et al. Mother-to-child transmission of human T-Cell lymphotropic viruses-1/2: what we know, and what are the gaps in understanding and preventing this route of infection. J Pediatr Infect Dis Soc. 2014;3(Suppl 1):S24–9.

    Article  Google Scholar 

  23. Rigourd V, Meyer V, Kieffer F, et al. HTLV and “donating” milk. Bull Soc Pathol Exot. 2011;104(3):205–8.

    Article  CAS  PubMed  Google Scholar 

  24. Take H, Umemoto M, Kusuhara K, et al. Transmission routes of HTLV-I: an analysis of 66 families. Jpn J Cancer Res. 1993;84(12):1265–7.

    Article  CAS  PubMed  Google Scholar 

  25. Fuchi N, Miura K, Imaizumi Y, et al. Adult T-cell leukemia-lymphoma in a pregnant woman diagnosed as a human T-cell lymphotropic virus type 1 carrier. J Obstet Gynaecol Res. 2016;42(3):336–40.

    Article  PubMed  Google Scholar 

  26. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol. 1991;79:428–37.

    Article  CAS  PubMed  Google Scholar 

  27. Shimoyama M. Chemotherapy of ATL. In: Takatsuki K, editor. Adult T-cell leukemia. Oxford: Oxford University Press; 1994. p. 221–37.

    Google Scholar 

  28. Takasaki Y, Iwanaga M, Imaizumi Y, et al. Long-term study of indolent adult T-cell leukemia–lymphoma. Blood. 2010;115:4337–43.

    Article  CAS  PubMed  Google Scholar 

  29. Ohba T, Matsuo I, Katabuchi H, et al. Adult T-cell leukemia/lymphoma in pregnancy. Obstet Gynecol. 1988;72:445–7.

    CAS  PubMed  Google Scholar 

  30. Utsumi T, Tsuda A, Hirano H, et al. A case of pregnancy with adult T-cell leukemia. J Obstet Gynaecol Res. 1996;22:599–601.

    Article  CAS  PubMed  Google Scholar 

  31. Safdar A, Johnson N, Gonzalez F, et al. Adult T-cell leukemia–lymphoma during pregnancy. N Engl J Med. 2002;346:2014–5.

    Article  PubMed  Google Scholar 

  32. Amor MM, Olaso AS, Atienza R, et al. Adult T-cell leukemia–lymphoma during pregnancy. Case Rep Oncol Med doi. 2013; doi:10.1155/2013/631825.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan

    Kiyonori Miura & Hideaki Masuzaki

Authors
  1. Kiyonori Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideaki Masuzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiyonori Miura .

Editor information

Editors and Affiliations

  1. Department of Medical Genome Sciences Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan

    Toshiki Watanabe

  2. Department of Clinical Laboratory Sciences School of Health Sciences, University of the Ryukyus, Okinawa, Japan

    Takuya Fukushima

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan KK

About this chapter

Cite this chapter

Miura, K., Masuzaki, H. (2017). Prevention of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Mother-to-Child Transmission. In: Watanabe, T., Fukushima, T. (eds) Adult T-cell Leukemia/Lymphoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56523-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56523-9_13

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56521-5

  • Online ISBN: 978-4-431-56523-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation